Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.050
-0.330 (-9.76%)
At close: Jul 15, 2025, 4:00 PM
3.080
+0.030 (0.98%)
After-hours: Jul 15, 2025, 4:00 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $113.77 million as of July 15, 2025. Its market cap has increased by 54.04% in one year.
Market Cap
113.77M
Enterprise Value
87.36M
1-Year Change
54.04%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $113.77M, a decrease of -19.71%. That is a compound annual growth rate of -8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 126.08M | 56.64% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |